NCT00274404View on ClinicalTrials.gov

Controlled Trial of Valacyclovir in Infectious Mononucleosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Infectious Mononucleosis
Interventions
DRUG

valacyclovir

Trial Locations (1)

55455-0392

University of Minnesota Clinical Virology Clinic, Minneapolis

Sponsors
All Listed Sponsors
collaborator

Minnesota Medical Foundation

OTHER

collaborator

Hoffmann-La Roche

INDUSTRY

lead

University of Minnesota

OTHER